Not long ago, it was taken as a given that we’d live longer than our parents – just as most of them lived longer and healthier lives than their own. But something strange has happened in the last 15 years or so. Increases in life expectancy have stalled, and there are signs it might even […]
Targeting final lead therapy selection, neutralizing all known previous and current SARS-CoV2 variants of concern by end 2022 Triple mode of action dengue fever program identified for development Industry veteran with exceptional leadership experience to support ExeVir’s new progressive pipeline against infectious diseases Ghent, Belgium, 20 Oct 2022: ExeVir is developing robust therapies providing broad protection […]
Management of Destiny Pharma (DEST), the AIM listed infection prevention biotechnology company, offer an overview of the Company, their platform and their late stage clinical assets heading towards phase 3 trails. The team expand on the anti infective market, their COVID 19 program and the strength of their balance sheet. The Company finish with their […]
Watch a replay of the live session here or read our top takeaways below…
As many countries continue to pass the peak of COVID-19, Masters Speciality Pharma’s Head of Licensing, Sid Masters believes now is a good time to reflect on the challenges, successes and response of the pharmaceutical industry during the pandemic. Sid writes: Over the past few months we have seen Covid-19 wreak havoc by crippling our […]
